In the early summer of Shencheng, when everything is growing rapidly, at this time of striving for progress, the 84th National Pharmaceutical Fair arrived as scheduled, and was held in the National Convention and Exhibition Center (Shanghai) from May 12 to May 14, 2021, with a scale of more than 100,000 square meters, bringing together more than 2,000 domestic and foreign production enterprises, and more than 120,000 professional visitors from more than 300 cities across the country to visit, which is a large-scale and influential professional event in China's pharmaceutical field, involving pharmaceutical research and development, production, All aspects of operation and service are the best places to take the pulse of the industry and the latest trends in the field of medicine, display the brand image of pharmaceutical companies, and negotiate cooperation with drug distributors.
Taking advantage of the policy, traditional Chinese medicine set sail. In the first year of the "14th Five-Year Plan", the traditional Chinese medicine market ushered in an unprecedented tide of policy dividends, and the development of traditional Chinese medicine pressed the acceleration button, and a whole industrial chain of pets was born in terms of treatment, prevention and maintenance. Benefiting from the support of national policies and the needs of residents for health care, the field of traditional Chinese medicine has sprung up and developed rapidly。
Hubei Mengyang Pharmaceutical Co., Ltd. was invited to participate in this event and exhibited in the V22 special booth of Hall 8.2, which fully demonstrated the company's excellent brand culture and star product lineup. The exhibition hall was extremely hot.
Founded in 2009, Mengyang Pharmaceutical Co., Ltd. is a joint-stock modern pharmaceutical high-tech enterprise, mainly engaged in the research and development, production and sales of natural medicines, chemical drugs and health foods. Focusing on the positioning of "a professional manufacturer of therapeutic drugs for the treatment of tumor treatment and side effects", the company is committed to becoming a leading drug R&D and production enterprise focusing on solving the toxic and side effects of tumor treatment in China. The company is located in Jingmen High-tech Zone, Hubei Province, and has formed an operation and management system with Jingmen as the production base, the establishment of a medicinal material provenance planting base and a traditional Chinese medicine decoction piece factory in Ningshan County, Shaanxi Province, an innovative drug R&D and production center in Shanghai, and a R&D and policy affairs center in Beijing. Mengyang Pharmaceutical, as a responsible and responsible national pharmaceutical company, will do its best to realize the dream of promoting the medicine of the motherland and bringing health to patients!
The company's blockbuster products such as Shengbai oral liquid, Zhuling polysaccharide capsules, and Zhijiao capsules were unveiled one by one. It has attracted the attention of many drug agents and distributors, and the booth site is crowded with people and continuous consultation. New and old customers stop to visit, ask for information, in-depth consultation of product information, exchange industry trends, and seek cooperation and development.
During the whole exhibition, a number of leaders of Mengyang Pharmaceutical Marketing Center and many colleagues from the sales, investment promotion and marketing departments of the national region were on duty at the booth with a full mental state, issued more than 1,000 promotional materials, received and communicated with nearly 1,000 people, fully publicized the company's brand and product advantages, consolidated the cooperative relationship with old customers, explored a group of potential customers, and laid a good foundation for the next step to expand the market.
